Tvardi Therapeutics (TVRD) Current Assets (2013 - 2026)

Tvardi Therapeutics (TVRD) posted Current Assets of $25.3 million for Q1 2026, down 19.7% sequentially from $31.5 million in Q4 2025.

Tvardi Therapeutics (TVRD) Current Assets (2013 - 2026) Analysis & Trends

Tvardi Therapeutics has reported Current Assets for 14 years, with the latest figure at $25.3 million in Q1 2026.

Quarterly Current Assets changed N/A year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (changed N/A YoY) and the FY2025 annual result came in at $31.5 million, changed 0.47% from the prior year.
Current Assets eased to $25.3 million in Q1 2026 per TVRD's latest filing, from $31.5 million in the prior quarter.
Over five years, Current Assets peaked at $186.8 million in Q3 2022 and troughed at $25.3 million in Q1 2026.
A 5-year average of $95.7 million and a median of $90.9 million in 2023 frame the typical range for Current Assets.
The sharpest annual moves came in 2022 and 2024: Current Assets grew 8.91% in 2022, then plunged 72.72% in 2024.
Over 5 years, Current Assets stood at $168.9 million in 2022, then tumbled by 31.23% to $116.2 million in 2023, then slumped by 72.72% to $31.7 million in 2024, then dropped by 0.47% to $31.5 million in 2025, then retreated by 19.7% to $25.3 million in 2026.
According to Business Quant data, Current Assets over the past three periods registered $25.3 million, $31.5 million, and $38.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	12.54 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	18.45 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	8.07 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	5.82 Bn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	7.22 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	4.62 Bn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	18.80 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.63 Bn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	1.76 Bn
10	Tvardi Therapeutics	17.36 Mn	17.36 Mn	-	17.07 Mn

Download Data